Stock News

Jarislowsky Fraser LTD Cut Abbott Laboratories (ABT) Position By $619,077; Raymond James Financial (RJF) Shorts Down By 16.68%

Abbott Laboratories (NYSE:ABT) Logo

Jarislowsky Fraser Ltd decreased Abbott Laboratories (ABT) stake by 0.45% reported in 2017Q4 SEC filing. Jarislowsky Fraser Ltd sold 10,861 shares as Abbott Laboratories (ABT)’s stock rose 5.88%. The Jarislowsky Fraser Ltd holds 2.38M shares with $135.75 million value, down from 2.39M last quarter. Abbott Laboratories now has $101.80B valuation. The stock decreased 0.03% or $0.015 during the last trading session, reaching $58.295. About 2.66 million shares traded. Abbott Laboratories (NYSE:ABT) has risen 34.85% since April 25, 2017 and is uptrending. It has outperformed by 23.30% the S&P500.

Raymond James Financial Inc (NYSE:RJF) had a decrease of 16.68% in short interest. RJF’s SI was 2.16 million shares in April as released by FINRA. Its down 16.68% from 2.60 million shares previously. With 950,100 avg volume, 2 days are for Raymond James Financial Inc (NYSE:RJF)’s short sellers to cover RJF’s short positions. The SI to Raymond James Financial Inc’s float is 1.74%. The stock decreased 0.58% or $0.5 during the last trading session, reaching $86.41. About 429,523 shares traded. Raymond James Financial, Inc. (NYSE:RJF) has risen 18.83% since April 25, 2017 and is uptrending. It has outperformed by 7.28% the S&P500.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 107 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Outperform” rating by RBC Capital Markets given on Friday, October 9. BMO Capital Markets maintained the stock with “Buy” rating in Wednesday, January 24 report. The firm earned “Hold” rating on Thursday, July 20 by BMO Capital Markets. The firm has “Buy” rating given on Thursday, July 20 by Stifel Nicolaus. As per Monday, January 4, the company rating was downgraded by Morgan Stanley. The firm has “Buy” rating by Argus Research given on Friday, July 21. Citigroup maintained the shares of ABT in report on Tuesday, January 30 with “Neutral” rating. The rating was maintained by Jefferies with “Buy” on Wednesday, April 18. Jefferies maintained Abbott Laboratories (NYSE:ABT) rating on Thursday, August 4. Jefferies has “Buy” rating and $52 target. The stock has “Buy” rating by Wells Fargo on Thursday, August 27.

Since December 14, 2017, it had 1 insider purchase, and 18 selling transactions for $23.52 million activity. $667,804 worth of Abbott Laboratories (NYSE:ABT) was sold by Fussell Stephen R on Wednesday, February 28. Funck Robert E also sold $71,970 worth of Abbott Laboratories (NYSE:ABT) shares. Blaser Brian J had sold 27,733 shares worth $1.73M. BIRD ROGER had sold 8,262 shares worth $518,450. Ford Robert B sold $2.69 million worth of stock or 42,665 shares. On Wednesday, February 28 the insider Salvadori Daniel Gesua Sive sold $53,369. The insider Watkin Jared sold 3,000 shares worth $183,579.

Jarislowsky Fraser Ltd increased General Electric Company (NYSE:GE) stake by 337,258 shares to 4.16M valued at $72.63 million in 2017Q4. It also upped Jpmorgan Chase & Co. (NYSE:JPM) stake by 68,108 shares and now owns 2.65 million shares. Walgreens Boots Alliance was raised too.

Investors sentiment increased to 0.91 in Q4 2017. Its up 0.04, from 0.87 in 2017Q3. It improved, as 52 investors sold ABT shares while 558 reduced holdings. 123 funds opened positions while 430 raised stakes. 1.22 billion shares or 0.64% more from 1.21 billion shares in 2017Q3 were reported. Employees Retirement Systems Of Texas has invested 0.31% in Abbott Laboratories (NYSE:ABT). Moreover, Morgan Stanley has 0.13% invested in Abbott Laboratories (NYSE:ABT) for 8.33 million shares. Butensky Cohen Security Inc reported 34,282 shares. Profund Advsrs Lc reported 0.14% in Abbott Laboratories (NYSE:ABT). Perigon Wealth Mngmt Lc stated it has 0.24% in Abbott Laboratories (NYSE:ABT). Cranbrook Wealth Management Limited Liability Company owns 580 shares for 0.01% of their portfolio. Investec Asset Mngmt Limited holds 264,414 shares or 0.06% of its portfolio. Thrivent For Lutherans stated it has 0.02% of its portfolio in Abbott Laboratories (NYSE:ABT). 168,926 were reported by Charter Comm. Nomura Asset Management has invested 0.3% in Abbott Laboratories (NYSE:ABT). Picton Mahoney Asset Management reported 433,800 shares. Benedict Advisors reported 56,540 shares. Foothills Asset Mgmt reported 26,336 shares or 1.14% of all its holdings. Washington Capital Mngmt reported 1.07% stake. Ipswich Investment Com stated it has 3,525 shares.

Since December 11, 2017, it had 0 insider purchases, and 8 insider sales for $6.66 million activity. Catanese George had sold 506 shares worth $44,675 on Friday, December 15. Shares for $455,000 were sold by ACKART JENNIFER C on Thursday, February 15. $1.44 million worth of Raymond James Financial, Inc. (NYSE:RJF) was sold by TROCIN JEFFREY E. Allison Paul D had sold 6,600 shares worth $637,894. 7,275 shares were sold by Elwyn Tashtego S, worth $708,327 on Monday, January 29. Shares for $1.97 million were sold by ZANK DENNIS W on Friday, March 9. 3,000 shares were sold by Bunn James E, worth $288,930 on Tuesday, January 30.

Investors sentiment increased to 1.21 in Q4 2017. Its up 0.18, from 1.03 in 2017Q3. It is positive, as 29 investors sold Raymond James Financial, Inc. shares while 139 reduced holdings. 60 funds opened positions while 143 raised stakes. 97.95 million shares or 0.86% more from 97.11 million shares in 2017Q3 were reported. Barclays Public Ltd invested 0.01% of its portfolio in Raymond James Financial, Inc. (NYSE:RJF). Novare Capital Mgmt Ltd Liability Co, North Carolina-based fund reported 6,350 shares. Employees Retirement Systems Of Texas stated it has 130,000 shares. Northwestern Mutual Wealth Mgmt Communications has 1,754 shares. Highland Capital Management Ltd Partnership owns 3,835 shares. Td Asset owns 0.01% invested in Raymond James Financial, Inc. (NYSE:RJF) for 43,503 shares. Fisher Asset Management Limited Liability Company stated it has 1.39M shares. Whittier Tru holds 0% in Raymond James Financial, Inc. (NYSE:RJF) or 171 shares. Balyasny Asset Ltd stated it has 141,464 shares or 0.04% of all its holdings. 4,941 are held by Global X Mngmt Limited Com. Quantitative Invest Limited Liability Com holds 53,100 shares. Aviva Public Ltd Company reported 67,406 shares. State Treasurer State Of Michigan has invested 0.03% of its portfolio in Raymond James Financial, Inc. (NYSE:RJF). Gateway Invest Advisers Lc holds 8,518 shares. Metropolitan Life Ins Com Ny reported 0.03% in Raymond James Financial, Inc. (NYSE:RJF).

Among 13 analysts covering Raymond James Financial Inc. (NYSE:RJF), 8 have Buy rating, 1 Sell and 4 Hold. Therefore 62% are positive. Raymond James Financial Inc. had 41 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of Raymond James Financial, Inc. (NYSE:RJF) has “Buy” rating given on Thursday, January 5 by Nomura. The rating was maintained by Wood with “Hold” on Thursday, May 25. The stock has “Neutral” rating by Citigroup on Tuesday, January 12. The rating was maintained by Keefe Bruyette & Woods with “Buy” on Thursday, April 5. On Friday, April 7 the stock rating was maintained by Wood with “Hold”. The firm has “Mkt Perform” rating by JMP Securities given on Friday, October 28. The firm earned “Outperform” rating on Tuesday, February 27 by Wood. As per Monday, December 5, the company rating was downgraded by Keefe Bruyette & Woods. The firm earned “Outperform” rating on Monday, February 22 by Credit Suisse. The stock of Raymond James Financial, Inc. (NYSE:RJF) earned “Neutral” rating by Citigroup on Monday, November 13.

Abbott Laboratories (NYSE:ABT) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *